These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11127392)

  • 41. Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma: analysis of the literature.
    Bielack SS; Beron G; Winkler K
    Cancer; 1997 Aug; 80(3):516-8. PubMed ID: 9241087
    [No Abstract]   [Full Text] [Related]  

  • 42. Reduced folate carrier mutations are not the mechanism underlying methotrexate resistance in childhood acute lymphoblastic leukemia.
    Kaufman Y; Drori S; Cole PD; Kamen BA; Sirota J; Ifergan I; Arush MW; Elhasid R; Sahar D; Kaspers GJ; Jansen G; Matherly LH; Rechavi G; Toren A; Assaraf YG
    Cancer; 2004 Feb; 100(4):773-82. PubMed ID: 14770434
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New Therapeutic Approach to Reduce Methotrexate Toxicity after High-Dose Chemotherapy in a Child with Acute Lymphocytic Leukemia: Efficacy and Safety of Hemoadsorption with HA-230 Adsorber.
    Sazonov V; Tobylbayeva Z; Saparov A; Jubaniyazov B; Issakov S; Gaipov A
    Blood Purif; 2022; 51(1):91-95. PubMed ID: 33725693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effects of high-dose methotrexate therapy on intestinal bacterial flora in children with acute lymphoblastic leukemia].
    Yang W; Liu H; Duan J; Zhang Y; Huang YK; He W; Lu P; Li HL
    Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):252-6. PubMed ID: 19099724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-dose methotrexate in acute lymphoblastic leukemia: where is the evidence for its continued use?
    Mantadakis E; Cole PD; Kamen BA
    Pharmacotherapy; 2005 May; 25(5):748-55. PubMed ID: 15899736
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brief report: effect of intravenous methotrexate dose and infusion rate on neuropsychological function one year after diagnosis of acute lymphoblastic leukemia.
    Carey ME; Hockenberry MJ; Moore IM; Hutter JJ; Krull KR; Pasvogel A; Kaemingk KL
    J Pediatr Psychol; 2007 Mar; 32(2):189-93. PubMed ID: 16675716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Occurrence and impact of unanticipated variation in intravenous methotrexate dosing.
    Parshuram CS; Dupuis LL; To T; Weitzman SS; Koren G; Laupacis A
    Ann Pharmacother; 2006 May; 40(5):805-11. PubMed ID: 16638922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Study on elimination delay in high dose methotrexate therapy in childhood acute lymphoblastic leukemia].
    Xu WQ; Tang YM; Fang CQ; Song H; Shi SW; Yang SL; Ren DT; Shen HQ; Qian BQ
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):15-8. PubMed ID: 15946502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical utility and pharmacology of high-dose methotrexate in the treatment of primary CNS lymphoma.
    Green MR; Chowdhary S; Lombardi KM; Chalmers LM; Chamberlain M
    Expert Rev Neurother; 2006 May; 6(5):635-52. PubMed ID: 16734512
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leucovorin and maximum tolerated dose toxicity of methotrexate in rats.
    Fuskevåg OM; Kristiansen C; Lindal S; Aarbakke J
    Pediatr Hematol Oncol; 2000 Dec; 17(8):651-8. PubMed ID: 11127396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methotrexate concentrations in cerebrospinal fluid and serum, and the risk of central nervous system relapse in children with acute lymphoblastic leukaemia.
    Jönsson P; Höglund P; Wiebe T; Schrøder H; Seidel H; Skärby T
    Anticancer Drugs; 2007 Sep; 18(8):941-8. PubMed ID: 17667600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Are we getting closer to using methotrexate in an optimal manner?
    Kamen BA; Bertino JR; Holcenberg JS; Bleyer WA
    J Clin Oncol; 2011 Sep; 29(25):3493-4; author reply 3494-5. PubMed ID: 21810689
    [No Abstract]   [Full Text] [Related]  

  • 53. High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma.
    Crews KR; Liu T; Rodriguez-Galindo C; Tan M; Meyer WH; Panetta JC; Link MP; Daw NC
    Cancer; 2004 Apr; 100(8):1724-33. PubMed ID: 15073863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of methylene tetrahydrofolate reductase polymorphisms and coadministration of antimetabolites on toxicity after high dose methotrexate.
    van Kooten Niekerk PB; Schmiegelow K; Schroeder H
    Eur J Haematol; 2008 Nov; 81(5):391-8. PubMed ID: 18691257
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation of cerebrospinal fluid beta-glucuronidase activity with plasma methotrexate concentrations in leukemic children receiving high-dose methotrexate.
    Vlacha V; Eliopoulou M; Haidas S; Beratis NG
    Pediatr Blood Cancer; 2004 Apr; 42(4):350-6. PubMed ID: 14966832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
    Counsel P; Khangure M
    Clin Radiol; 2007 Feb; 62(2):172-6. PubMed ID: 17207701
    [No Abstract]   [Full Text] [Related]  

  • 57. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
    Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
    Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methotrexate-induced bullous acral erythema in a child.
    Werchniak AE; Chaffee S; Dinulos JG
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S93-5. PubMed ID: 15858519
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does pharmacokinetic variability influence the efficacy of high-dose methotrexate for the treatment of children with acute lymphoblastic leukemia: what can we learn from small studies?
    Evans WE; Relling MV; Boyett JM; Pui CH
    Leuk Res; 1997 May; 21(5):435-7. PubMed ID: 9225072
    [No Abstract]   [Full Text] [Related]  

  • 60. Severe acute renal failure following high-dose methotrexate therapy in adults with haematological malignancies: a significant number result from unrecognized co-administration of several drugs.
    de Miguel D; García-Suárez J; Martín Y; Gil-Fernández JJ; Burgaleta C
    Nephrol Dial Transplant; 2008 Dec; 23(12):3762-6. PubMed ID: 18779628
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.